HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effects of pentazocine and other opiates on shock detection in the rat: involvement of opiate and dopamine receptors.

Abstract
The hypothesis that the antinociceptive effects of pentazocine, a mixed agonist-antagonist opiate of the benzomorphan class, are mediated by a dual opiate-dopaminergic mechanism was tested using a two-choice procedure in which rats were required to discriminate the presence or absence of shock. The results showed that pentazocine decreased shock sensitivity and speed of responding, effects that were qualitatively similar to those of morphine. However, while the antinociceptive effect of both pentazocine and morphine could be antagonized by opiate receptor blockage, that of pentazocine, but not of morphine, could also be antagonized by dopamine receptor blockade. Observations with levorphanol and phenazocine suggested further that dopamine, as well as opiate receptor agonism may be characteristic of the benzomorphans.
AuthorsL L Hernández, J B Appel
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 67 Issue 2 Pg. 155-63 (Feb 1980) ISSN: 0033-3158 [Print] GERMANY, WEST
PMID6245423 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Narcotics
  • Receptors, Dopamine
  • Receptors, Opioid
  • Naltrexone
  • Morphine
  • Pentazocine
Topics
  • Animals
  • Electroshock
  • Male
  • Morphine (pharmacology)
  • Naltrexone (pharmacology)
  • Narcotics (pharmacology)
  • Pentazocine (pharmacology)
  • Prejudice (drug effects)
  • Rats
  • Receptors, Dopamine (physiology)
  • Receptors, Opioid (physiology)
  • Reinforcement Schedule

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: